PERFORMANCE OF NON-INVASIVE TESTS (NITS) AND PREDICTORS OF OUTCOMES IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) FROM LATIN AMERICA AND NORTH AMERICA

作者
Zobair M. Younossi,Leyla de Avila,Claudia Pinto Marques Souza de Oliveira,Cristiane Alves Villela‐Nogueira,Marlén Ivón Castellanos Fernández,Adrian Carlos Gadano,Marco Antonio Arrese Jimenez,Naim Alkhouri,Winston Dunn,Giada Sebastiani,Luis Antonio Díaz Piga,Brian L. Pearlman,Juan Pablo Arab,Rida Nadeem,Felice Cinque,Nicholas Dunn,Licet González Fabián,Ahmed Almohsen,Nathalie Carvalho Leite,Ethan Friend
出处
期刊:Annals of Hepatology [Elsevier BV]
卷期号:30: 101951-101951
标识
DOI:10.1016/j.aohep.2025.101951
摘要

MASLD is highly prevalent worldwide. We evaluated performance of NITs and predictors of outcomes in patients with MASLD from Latin America (LA) as compared to North America (NA). The Global-MASLD project enrolled MASLD patients with liver biopsies and NITs (FIB-4, liver stiffness measurement (LSM) by transient elastography). NITs’ performance to predict advanced fibrosis (AF=F3-F4) and outcomes was assessed. A total of 3,904 MASLD patients were included [N=892 from 5 LA countries (Argentina, Brazil, Chile, Cuba, Mexico) and N=3012 from NA (USA/Canada). MASLD patients from LA were older, had lower BMI (obesity 64% vs. 85%), more lean MASLD (5.6% vs. 2.7%), more T2D (49% vs. 38%) (p<0.001) but similar rates of AF (p=0.56). Clinico-demographic predictors of AF included older age and T2D (p<0.05). The NIT accuracy was lower in LA-MASLD than NA-MASLD: AUC (95% CI) of FIB-4 0.75 (0.71-0.79) vs. 0.81 (0.79-0.83), LSM 0.73 (0.67-0.80) vs. 0.78 (0.75-0.81), Agile-3+ 0.76 (0.70-0.82) for both LA and NA. Sensitivity of 80% (low-risk, screening cutoff) was achieved with FIB-4 ≥1.01 in LA vs. FIB-4 ≥1.17 in NA; specificity of 95% (high-risk, diagnostic cutoff) with FIB-4 ≥2.35 vs. FIB-4 ≥2.40. In adjusted (age, sex, T2D) proportional hazards models, fibrosis severity by histology or NITs was associated with adverse outcomes (death, decompensation, HCC) in both groups (adjusted hazard ratios (aHR) >1.0) (Figure). MASLD patients from LA have more T2D but less obesity than NA. Common NITs have lower accuracy in LA-MASLD. Histologic and NIT stage of fibrosis are independent predictors of adverse outcomes in both groups.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
天天向上的应助被科研通管家采纳,获得10
刚刚
robert2021的应助被科研通管家采纳,获得100
刚刚
刚刚
彭于晏的应助被科研通管家采纳,获得10
刚刚
慕青的应助被科研通管家采纳,获得10
刚刚
zzz发布了新的文献求助10
刚刚
深情安青的应助被科研通管家采纳,获得10
刚刚
天天向上的应助被科研通管家采纳,获得10
1秒前
852的应助被科研通管家采纳,获得10
1秒前
皮卡丘发布了新的文献求助10
1秒前
1秒前
Akim的应助被科研通管家采纳,获得10
1秒前
天天向上的应助被科研通管家采纳,获得10
1秒前
小蘑菇的应助被科研通管家采纳,获得10
1秒前
1秒前
共享精神的应助被科研通管家采纳,获得10
1秒前
赘婿的应助被科研通管家采纳,获得10
2秒前
打打的应助被TJL采纳,获得10
2秒前
Lucas的应助被科研通管家采纳,获得10
2秒前
2秒前
初景的应助被科研通管家采纳,获得20
2秒前
Akim的应助被科研通管家采纳,获得10
2秒前
酷波er的应助被科研通管家采纳,获得10
2秒前
2秒前
2秒前
共享精神的应助被科研通管家采纳,获得10
2秒前
2秒前
斯文败类的应助被科研通管家采纳,获得10
2秒前
充电宝的应助被科研通管家采纳,获得10
3秒前
科研通AI65的应助被zxxzxx采纳,获得10
3秒前
不以发布了新的文献求助10
3秒前
3秒前
王晨发布了新的文献求助10
4秒前
4秒前
5秒前
5秒前
6秒前
wg发布了新的文献求助10
6秒前
庞mou完成签到,获得积分10
6秒前
小蘑菇的应助被阿萍采纳,获得10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188088
求助须知:如何正确求助?哪些是违规求助? 9575942
关于积分的说明 21844291
捐赠科研通 7785857
什么是DOI,文献DOI怎么找? 3435158
关于科研通互助平台的介绍 2559529
邀请新用户注册赠送积分活动 2482065